Perrigo's generic Mirvaso gets tentative FDA approval

05:15 EDT 7 Aug 2017 | SmartBrief

The FDA has granted tentative approval to Perrigo's generic version of Galderma Laboratories' Mirvaso, or brimonidine topical -More

Original Article: Perrigo's generic Mirvaso gets tentative FDA approval


More From BioPortfolio on "Perrigo's generic Mirvaso gets tentative FDA approval"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mirvaso (brimonidine)
MIRVASO® (BRIMONIDINE) TOPICAL GEL, 0.33%* IS THE FIRST & ONLY FDA-APPROVED TREATMENT DEVELOPED AND INDICATED FOR PERSISTENT FACIAL REDNESS OF ROSACEA Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for th...